Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies

Journal of Glaucoma

Volumn 13, Issue 3, 2004, Pages 221-226

  Strutton, David R ^a   Walt, John G ^b  

^a Galt Associates Inc   (United States)

^b ALLERGAN INC   (United States)

Author keywords

Glaucoma; Latanoprost; Medicare; Surgery

Indexed keywords

ANTIGLAUCOMA AGENT; LATANOPROST; PROSTAGLANDIN DERIVATIVE;

AMBULATORY SURGERY; ARTICLE; GLAUCOMA SURGERY; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MEDICARE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ANTIHYPERTENSIVE AGENTS; DRUG THERAPY; DRUG UTILIZATION; FILTERING SURGERY; GLAUCOMA, OPEN-ANGLE; HUMANS; INPATIENTS; MEDICARE; OPHTHALMIC SOLUTIONS; OUTPATIENTS; PREVALENCE; PROSTAGLANDINS F, SYNTHETIC; QUINOXALINES; SULFONAMIDES; THIOPHENES; UNITED STATES;

EID: 2442712763     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200406000-00008     Document Type: Article

References (20)

1. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38:83-91.
2. Quigley HA. Open-angle glaucoma. N Engl J Med. 1993;328:1097-1106.
3. Weinreb RN. A rationale for lowering intraocular pressure in glaucoma. Surv Ophthalmol. 2001;45(Suppl 4):S335-S336.
4. Marchetti A, Magar R, An P, et al. Clinical and economic impact of new trends in glaucoma treatment. MedGenMed 2001;3. Available at: www.medscape.com/viewarticles/408155_print. Accessed 3 September 2002.
5. Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study. Interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108:1954-1965.
6. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1953.
7. Musch DC, Lichter PR, Guire KE, et al. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653-662.
8. The Glaucoma Laser Trial and Glaucoma Laser Trial Follow-up Study. Results. Am J Ophthalmol. 1995;120:718-731.
9. Whittaker KW, Gillow JT, Cunliffe IA. Is the role of trabeculectomy in glaucoma management changing? Eye. 2001;15:449-452.
10. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 1994;101:1651-1656.
11. Edmunds B, Thompson JR, Salmon JF, et al. The National Survey of Trabeculectomy. I. Sample and methods. Eye. 1999;13:524-530.
12. Johnstone MA, Shingleton BJ, Crandall AS, et al. Glaucoma surgery treatment patterns of ASCRS members - 2000 survey. J Cataract Refract Surg. 2001;27:1864-1871.
13. Bateman DN, Clark R, Azuara-Blanco A, et al. The effects of new topical treatments on management of glaucoma in Scotland: An examination of ophthalmological health care. Br J Ophthalmol. 2002;86:551-554.
14. Bateman DN, Clark R, Azuara-Blanco A, et al. The impact of new drugs on management of glaucoma in Scotland: observational study. BMJ. 2001;323:1401-1402.
15. Paikal D, Yu F, Coleman AL. Trends in glaucoma surgery incidence and reimbursement for physician services in the Medicare population from 1995 to 1998. Ophthalmology. 2002;109:1372-1376.
16. Linden C. Therapeutic potential of prostaglandin analogues in glaucoma. Expert Opin Investig Drugs. 2001;10:679-694.
17. Watson PG. Latanoprost: Two years' experience of its use in the United Kingdom. Ophthalmology. 1998;105:82-87.
18. Hejkal TW, Camras CB. Prostaglandin analogues in the treatment of glaucoma. Semin Ophthalmol. 1999;14:114-123.
19. Samalonis LB. What does the future hold? Available at: www.eyeworld. org/jan02/0102p24.html. Accessed 3 September 2002.
20. Albright CD, Schuman SG, Netland PA. Usage and cost of laser trabeculoplasty in the United States. Ophthalmic Surg Lasers. 2002;33:334-336.